D. E. Shaw & Co., Inc. Seagen Inc. Transaction History

D. E. Shaw & Co., Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $164 Million - $185 Million	857,279 Added 3948.41%	878,991 $186 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $746,244 - $820,256	3,977 Added 22.42%	21,712 $4.18 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $10.1 Million - $16.1 Million	-79,193 Reduced 81.7%	17,735 $3.59 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $1.63 Million - $1.94 Million	13,909 Added 16.75%	96,928 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $8.48 Million - $11.3 Million	62,674 Added 308.06%	83,019 $11.4 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $210,220 - $346,465	1,932 Added 10.49%	20,345 $3.6 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $5.05 Million - $6.67 Million	-42,249 Reduced 69.65%	18,413 $2.65 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $30.4 Million - $40.7 Million	-212,994 Reduced 77.83%	60,662 $9.38 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $16.5 Million - $19.7 Million	-115,798 Reduced 29.73%	273,656 $46.5 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $17.6 Million - $21 Million	-130,138 Reduced 25.05%	389,454 $61.5 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $71.4 Million - $99.1 Million	519,592 New	519,592 $72.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.